Secondary |
Drug Use For Unknown Indication |
25.4% |
Hypertension |
17.9% |
Drug Exposure In Utero |
14.9% |
Migraine |
6.0% |
Infection Parasitic |
4.5% |
Pain |
4.5% |
Product Used For Unknown Indication |
4.5% |
Arterial Thrombosis |
3.0% |
Back Pain |
3.0% |
Analgesia |
1.5% |
Blood Cholesterol Increased |
1.5% |
Diabetes Mellitus |
1.5% |
Erectile Dysfunction |
1.5% |
Essential Hypertension |
1.5% |
Fungal Infection |
1.5% |
Hypothyroidism |
1.5% |
Infection |
1.5% |
Insomnia |
1.5% |
Psoriatic Arthropathy |
1.5% |
Shoulder Pain |
1.5% |
|
Syncope |
22.2% |
Metabolic Acidosis |
16.7% |
Migraine |
11.1% |
Dizziness |
5.6% |
Drug Effect Decreased |
5.6% |
Insomnia |
5.6% |
Intentional Overdose |
5.6% |
Renal Impairment |
5.6% |
Sinus Tachycardia |
5.6% |
Speech Disorder Developmental |
5.6% |
Vasculitis |
5.6% |
Weight Increased |
5.6% |
|
Concomitant |
Product Used For Unknown Indication |
21.9% |
Cancer Pain |
12.1% |
Prophylaxis |
9.6% |
Prostate Cancer Metastatic |
6.5% |
Prostate Cancer |
6.4% |
Hypertension |
5.9% |
Pain |
4.1% |
Back Pain |
3.7% |
Crohn's Disease |
3.4% |
Diabetes Mellitus |
3.1% |
Drug Use For Unknown Indication |
3.0% |
Rheumatoid Arthritis |
2.7% |
Spinal Cord Compression |
2.7% |
Infection |
2.4% |
Nausea |
2.4% |
Vitamin Supplementation |
2.2% |
Constipation |
2.1% |
Prophylaxis Of Nausea And Vomiting |
2.1% |
Anxiety |
1.9% |
Hormone Therapy |
1.9% |
|
Hepatic Encephalopathy |
7.8% |
Vomiting |
7.8% |
Sepsis |
6.3% |
Terminal State |
6.3% |
Therapeutic Response Decreased |
6.3% |
Weight Increased |
6.3% |
Incorrect Dose Administered |
4.7% |
Intestinal Obstruction |
4.7% |
Myalgia |
4.7% |
Pneumonia |
4.7% |
Post Procedural Haemorrhage |
4.7% |
Pulmonary Embolism |
4.7% |
Rectal Haemorrhage |
4.7% |
Respiratory Tract Infection |
4.7% |
Somnolence |
4.7% |
Spinal Cord Compression |
4.7% |
Hyperventilation |
3.1% |
Melaena |
3.1% |
Musculoskeletal Pain |
3.1% |
Nausea |
3.1% |
|
Interacting |
Smoking Cessation Therapy |
100.0% |
|
|